DARE
Price:
$1.79
Market Cap:
$17.04M
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal diso...[Read more]
Industry
Biotechnology
IPO Date
2014-04-10
Stock Exchange
NASDAQ
Ticker
DARE
According to Daré Bioscience, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.98. This represents a change of -32.97% compared to the average of -1.46 of the last 4 quarters.
The mean historical PE Ratio of Daré Bioscience, Inc. over the last ten years is -4.39. The current -0.98 PE Ratio has changed 2.13% with respect to the historical average. Over the past ten years (40 quarters), DARE's PE Ratio was at its highest in in the June 2022 quarter at 63.41. The PE Ratio was at its lowest in in the December 2016 quarter at -119051.06.
Average
-4.39
Median
-1.87
Minimum
-21.58
Maximum
-0.46
Discovering the peaks and valleys of Daré Bioscience, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 586.44%
Maximum Annual PE Ratio = -0.46
Minimum Annual Increase = -89.85%
Minimum Annual PE Ratio = -21.58
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -6.54 | 586.44% |
| 2023 | -0.95 | -58.00% |
| 2022 | -2.27 | -28.23% |
| 2021 | -3.16 | 114.74% |
| 2020 | -1.47 | 64.37% |
| 2019 | -0.90 | 96.47% |
| 2018 | -0.46 | -25.05% |
| 2017 | -0.61 | -89.85% |
| 2016 | -5.99 | -72.24% |
| 2015 | -21.58 | -53.62% |
The current PE Ratio of Daré Bioscience, Inc. (DARE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.25
5-year avg
-2.88
10-year avg
-4.39
Daré Bioscience, Inc.’s PE Ratio is less than FibroBiologics, Inc. Common Stock (-0.76), less than Citius Pharmaceuticals, Inc. (-0.34), less than Leap Therapeutics, Inc. (-0.80), less than Ainos, Inc. (-0.76), less than Athira Pharma, Inc. (-0.41), less than Aspire Biopharma Holdings, Inc. (-0.16), less than Aditxt, Inc. (-0.00), greater than Palisade Bio, Inc. (-1.20), less than Adlai Nortye Ltd. (-0.25), greater than Hoth Therapeutics, Inc. (-1.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.76 | $10.90M | |
| -0.34 | $13.97M | |
| -0.80 | $52.15M | |
| -0.76 | $12.03M | |
| -0.41 | $15.36M | |
| -0.16 | $4.56M | |
| -0.00 | $62.61K | |
| -1.20 | $268.21M | |
| -0.25 | $37.48M | |
| -1.54 | $15.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daré Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Daré Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Daré Bioscience, Inc.'s PE Ratio?
How is the PE Ratio calculated for Daré Bioscience, Inc. (DARE)?
What is the highest PE Ratio for Daré Bioscience, Inc. (DARE)?
What is the 3-year average PE Ratio for Daré Bioscience, Inc. (DARE)?
What is the 5-year average PE Ratio for Daré Bioscience, Inc. (DARE)?
How does the current PE Ratio for Daré Bioscience, Inc. (DARE) compare to its historical average?